d(+)fructofuranose 1,6-diphosphate tetra(cyclohexylammonium) salt

Suppliers

Names

[ CAS No. ]:
103213-44-1

[ Name ]:
d(+)fructofuranose 1,6-diphosphate tetra(cyclohexylammonium) salt

[Synonym ]:
D-FRUCTOSE 1,6-DIPHOSPHATE TETRA(CYCLOHEXYLAMMONIUM) SALT
HEXOSE DIPHOSPHATE TETRA(CYCLOHEXYLAMMONIUM) SALT
HARDEN-YOUNG ESTER TETRA(CYCLOHEXYLAMMONIUM) SALT
D-Tagatose-1,6-bisphosphat tetrakis(cyclohexylammonium) Salz
d-fructose 1,6-bisphosphate tetra(cyclohexylammonium) salt
D-FRUCTOSE 1,6-DIPHOSPHATE*TETRA(CYCLOHE XYMAMMONIUM

Chemical & Physical Properties

[ Molecular Formula ]:
C6H26N4O12P2

[ Molecular Weight ]:
408.23800

[ Exact Mass ]:
408.10200

[ PSA ]:
242.22000

[ LogP ]:
0.11440

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Safety Phrases ]:
22-24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 1,3-Dihydroxyacetone
  • dihydroxyacetone phosphate
  • (2-hydroxy-3-oxopropyl) phosphate

DownStream

  • dihydroxyacetone phosphate
  • (2-hydroxy-3-oxopropyl) phosphate

Articles

Fructose-1,6-bisphosphate attenuates induction of nitric oxide synthase in microglia stimulated with lipopolysaccharide.

Life Sci. 90(9-10) , 365-72, (2011)

Fructose-1,6-bisphosphate (FBP) is a glycolytic intermediate with neuroprotective action in various brain injury models. However, the mechanism underlying the neuroprotection of FBP has not been fully...

Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.

Handbook of Experimental Pharmacology 203 , 279-301, (2011)

Fructose-1,6-bisphosphatase (FBPase), a rate-controlling enzyme of gluconeogenesis, has emerged as an important target for the treatment of type 2 diabetes due to the well-recognized role of excessive...

Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.

Diabetes 55 , 1747-1754, (2006)

Gluconeogenesis is increased in type 2 diabetes and contributes significantly to fasting and postprandial hyperglycemia. We recently reported the discovery of the first potent and selective inhibitors...


More Articles

Related Compounds

  • N-(5-methyl-1,3-thiazol-2-yl)-1-[3-(propan-2-yl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidine-4-carboxamide
  • N-(3,4-dimethoxybenzyl)-3-(2-methoxyphenyl)-4-oxo-3,4-dihydroquinazoline-7-carboxamide
  • N-(4-fluorobenzyl)-3-(3-methoxyphenyl)-4-oxo-3,4-dihydroquinazoline-7-carboxamide
  • 3-(2-methoxyphenyl)-N-(2-methylpropyl)-4-oxo-3,4-dihydroquinazoline-7-carboxamide
  • Acetamide, 2-(butylcyclopropylamino)-N-(4-cyanophenyl)-
  • N-{4-[methyl(phenyl)sulfamoyl]phenyl}-3-phenyl-5,6-dihydro-1,4-oxathiine-2-carboxamide
  • N-[3-(1,3-benzothiazol-2-yl)-1-(2-methoxyethyl)-4,5-dimethyl-1H-pyrrol-2-yl]-3-methoxybenzamide
  • 3-(4-Fluorophenyl)-1,2-benzoxazol-6-yl thiophene-2-sulfonate
  • N-(1H-indol-6-yl)-2-[(2-oxo-4-propyl-2H-chromen-7-yl)oxy]acetamide
  • N-(1H-indol-6-yl)-2-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]acetamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.